Adolescent Boys With High BMI Are at Risk for Moderate to Severe OSA
Adolescent boys with a higher BMI, adenotonsillar hypertrophy, and sleep-disordered breathing have an increased risk for moderate to severe obstructive sleep apnea.
Obstructive Sleep Apnea
VA/DoD Provides Screening Algorithm, Management Pathway for Insomnia and OSA
The VA/DoD clinical practice guideline offers a paradigm shift for treating veterans with chronic insomnia or obstructive sleep apnea.
Lack of Knowledge on Idiopathic Hypersomnia Often Leads to Misdiagnosis
A survey of health care providers found a lack of knowledge on idiopathic hypersomnia (IH) among physicians, and that the disorder is often misdiagnosed. We spoke with Richard Bogan, MD, FCCP, FAASM, associate clinical professor at the University of the South Carolina School of Medicine about IH and criteria for diagnosing this sleep disorder.
Solriamfetol Improves Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, improves excessive daytime sleepiness in OSA regardless of primary OSA therapy adherence.
Untreated Obstructive Sleep Apnea Linked to More Influenza Hospitalizations
There may be increased hospitalization risk from influenza infection in patients with obstructive sleep apnea who do not use continuous positive airway pressure.
Treatment Improves Chronic Pain Outcomes Associated With Poor Sleep
A systematic scoping review examines the literature about the influence of sleep disorders and disturbance on pain outcomes among US veterans with chronic nonmalignant pain.
Novel Rx Device for Sleep Apnea, Snoring Gets FDA Approval
The eXciteOSA device is used while the individual is awake and provides electrical muscle stimulation through a mouthpiece that sits around the tongue.
Obstructive Sleep Apnea During the COVID-19 Pandemic: Increased Mortality Risk and Viral Spread
Researchers reviewed COVID-19 literature to determine the relationship between obstructive sleep apnea (OSA) and adverse COVID-19 outcomes.
Solriamfetol Improves Driving Performance in Patients With Excessive Daytime Sleepiness and Obstructive Sleep Apnea
Researchers evaluated the effects of solriamfetol on driving performance in patients with excessive daytime sleepiness and obstructive sleep apnea.
Snoring Predicts Risk of Cerebral Events in Patients With OSA and CVD
Snoring is associated with increased risk of cerebral events in patients with obstructive sleep apnea and established cardiovascular disease.
- Loading...
Loading...
Next post in Sleep Information Center
Loading... 
Loading...